Sign in Check my fit
EN

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Open now · Grant · RFA-DA-25-060

Next cut-off
05 Mar '27
in 180 days
Per grant
$1.5M
the call's own average
Grants expected
,
not published for this call
Funding rate
,
not published, read the conditions

In context of US Department of Health and Human Services

This grant$1.5M
The track runs to the largest grant in US Department of Health and Human Services ($42M). The median across the 961 calls we publish is $749K, this one is above it.

What this call funds

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

What applying costs you

ItemEstimateNote
Drafting effort3–4 weekssingle submission
Time to first payment6–9 monthscut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Also open in HHS

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit